Behavioral Pharmacology of Maprotiline, a New Antidepressant

Showa Ueki, Michihiro Fujiwara, Kazuhide Inoue, Yasufumi Kataoka, Nobuhiro Ibii, Yukio Wada

研究成果: ジャーナルへの寄稿記事

8 引用 (Scopus)

抄録

The effect of maprotiline (N-methyl-9, 10-ethanoanthracene-9(10H)-propylamine) on animal behavior was investigated in mice and rats and compared with those of amitriptyline and imipramine. Maprotiline inhibited reserpine hypothermia in mice and tetrabenazine ptosis in rats, while it potentiated the effects of methamphetamine, L-DOPA and apomorphine in mice, in a similar manner to that of amitriptyline and imipramine. Maprotiline was more potent than amitriptyline and imipramine in antagonizing haloperidol-induced catalepsy as well as in suppressing muricide induced by either olfactory bulbectomy or delta-9-tetrahydrocannabinol in rats. Maprotiline potentiated anesthesia induced by thiopental or ether in mice to a lesser degree than did amitriptyline, and failed to counteract the lethal effect of physostigmine or oxotremorine tremor in mice, indicating that this drug has no central anti-cholinergic effect. Maprotiline markedly inhibited hyperemo tionality of the rat with either septal lesions or olfactory bulb ablations, suggesting that it does have a tranquilizing effect. Inhibition of conditioned avoidance response of the rat in shuttle box and reduction of methamphetamine group toxicity with maprotiline were similar to those with amitriptyline. Maprotiline exaggerated pentetrazol convulsion, decreased muscle tone and impaired coordinated motor activity in mice to a much lesser degree than amitriptyline and imipramine. LD50 of maprotiline was approximately twice that of imipramine and three times that of amitriptyline. These results indicate that maprotiline is a new type of antidepressant, has a low toxicity and shares both potent antidepressant and some tranquilizing effect, without possessing central anticholinergic action.

元の言語英語
ページ(範囲)789-815
ページ数27
ジャーナルFolia Pharmacologica Japonica
71
発行部数8
DOI
出版物ステータス出版済み - 1 1 1975

Fingerprint

Maprotiline
Antidepressive Agents
Amitriptyline
Pharmacology
Imipramine
Tranquilizing Agents
Methamphetamine
Cholinergic Antagonists
Tetrabenazine
Oxotremorine
Catalepsy
Animal Behavior
Physostigmine
Muscle Hypotonia
Dronabinol
Thiopental
Apomorphine
Olfactory Bulb
Lethal Dose 50
Reserpine

All Science Journal Classification (ASJC) codes

  • Pharmacology

これを引用

Behavioral Pharmacology of Maprotiline, a New Antidepressant. / Ueki, Showa; Fujiwara, Michihiro; Inoue, Kazuhide; Kataoka, Yasufumi; Ibii, Nobuhiro; Wada, Yukio.

:: Folia Pharmacologica Japonica, 巻 71, 番号 8, 01.01.1975, p. 789-815.

研究成果: ジャーナルへの寄稿記事

Ueki, S, Fujiwara, M, Inoue, K, Kataoka, Y, Ibii, N & Wada, Y 1975, 'Behavioral Pharmacology of Maprotiline, a New Antidepressant', Folia Pharmacologica Japonica, 巻. 71, 番号 8, pp. 789-815. https://doi.org/10.1254/fpj.71.789
Ueki, Showa ; Fujiwara, Michihiro ; Inoue, Kazuhide ; Kataoka, Yasufumi ; Ibii, Nobuhiro ; Wada, Yukio. / Behavioral Pharmacology of Maprotiline, a New Antidepressant. :: Folia Pharmacologica Japonica. 1975 ; 巻 71, 番号 8. pp. 789-815.
@article{5c17ec9ea13a4912bbd201e7c0d42013,
title = "Behavioral Pharmacology of Maprotiline, a New Antidepressant",
abstract = "The effect of maprotiline (N-methyl-9, 10-ethanoanthracene-9(10H)-propylamine) on animal behavior was investigated in mice and rats and compared with those of amitriptyline and imipramine. Maprotiline inhibited reserpine hypothermia in mice and tetrabenazine ptosis in rats, while it potentiated the effects of methamphetamine, L-DOPA and apomorphine in mice, in a similar manner to that of amitriptyline and imipramine. Maprotiline was more potent than amitriptyline and imipramine in antagonizing haloperidol-induced catalepsy as well as in suppressing muricide induced by either olfactory bulbectomy or delta-9-tetrahydrocannabinol in rats. Maprotiline potentiated anesthesia induced by thiopental or ether in mice to a lesser degree than did amitriptyline, and failed to counteract the lethal effect of physostigmine or oxotremorine tremor in mice, indicating that this drug has no central anti-cholinergic effect. Maprotiline markedly inhibited hyperemo tionality of the rat with either septal lesions or olfactory bulb ablations, suggesting that it does have a tranquilizing effect. Inhibition of conditioned avoidance response of the rat in shuttle box and reduction of methamphetamine group toxicity with maprotiline were similar to those with amitriptyline. Maprotiline exaggerated pentetrazol convulsion, decreased muscle tone and impaired coordinated motor activity in mice to a much lesser degree than amitriptyline and imipramine. LD50 of maprotiline was approximately twice that of imipramine and three times that of amitriptyline. These results indicate that maprotiline is a new type of antidepressant, has a low toxicity and shares both potent antidepressant and some tranquilizing effect, without possessing central anticholinergic action.",
author = "Showa Ueki and Michihiro Fujiwara and Kazuhide Inoue and Yasufumi Kataoka and Nobuhiro Ibii and Yukio Wada",
year = "1975",
month = "1",
day = "1",
doi = "10.1254/fpj.71.789",
language = "English",
volume = "71",
pages = "789--815",
journal = "Folia Pharmacologica Japonica",
issn = "0015-5691",
publisher = "Japanese Pharmacological Society",
number = "8",

}

TY - JOUR

T1 - Behavioral Pharmacology of Maprotiline, a New Antidepressant

AU - Ueki, Showa

AU - Fujiwara, Michihiro

AU - Inoue, Kazuhide

AU - Kataoka, Yasufumi

AU - Ibii, Nobuhiro

AU - Wada, Yukio

PY - 1975/1/1

Y1 - 1975/1/1

N2 - The effect of maprotiline (N-methyl-9, 10-ethanoanthracene-9(10H)-propylamine) on animal behavior was investigated in mice and rats and compared with those of amitriptyline and imipramine. Maprotiline inhibited reserpine hypothermia in mice and tetrabenazine ptosis in rats, while it potentiated the effects of methamphetamine, L-DOPA and apomorphine in mice, in a similar manner to that of amitriptyline and imipramine. Maprotiline was more potent than amitriptyline and imipramine in antagonizing haloperidol-induced catalepsy as well as in suppressing muricide induced by either olfactory bulbectomy or delta-9-tetrahydrocannabinol in rats. Maprotiline potentiated anesthesia induced by thiopental or ether in mice to a lesser degree than did amitriptyline, and failed to counteract the lethal effect of physostigmine or oxotremorine tremor in mice, indicating that this drug has no central anti-cholinergic effect. Maprotiline markedly inhibited hyperemo tionality of the rat with either septal lesions or olfactory bulb ablations, suggesting that it does have a tranquilizing effect. Inhibition of conditioned avoidance response of the rat in shuttle box and reduction of methamphetamine group toxicity with maprotiline were similar to those with amitriptyline. Maprotiline exaggerated pentetrazol convulsion, decreased muscle tone and impaired coordinated motor activity in mice to a much lesser degree than amitriptyline and imipramine. LD50 of maprotiline was approximately twice that of imipramine and three times that of amitriptyline. These results indicate that maprotiline is a new type of antidepressant, has a low toxicity and shares both potent antidepressant and some tranquilizing effect, without possessing central anticholinergic action.

AB - The effect of maprotiline (N-methyl-9, 10-ethanoanthracene-9(10H)-propylamine) on animal behavior was investigated in mice and rats and compared with those of amitriptyline and imipramine. Maprotiline inhibited reserpine hypothermia in mice and tetrabenazine ptosis in rats, while it potentiated the effects of methamphetamine, L-DOPA and apomorphine in mice, in a similar manner to that of amitriptyline and imipramine. Maprotiline was more potent than amitriptyline and imipramine in antagonizing haloperidol-induced catalepsy as well as in suppressing muricide induced by either olfactory bulbectomy or delta-9-tetrahydrocannabinol in rats. Maprotiline potentiated anesthesia induced by thiopental or ether in mice to a lesser degree than did amitriptyline, and failed to counteract the lethal effect of physostigmine or oxotremorine tremor in mice, indicating that this drug has no central anti-cholinergic effect. Maprotiline markedly inhibited hyperemo tionality of the rat with either septal lesions or olfactory bulb ablations, suggesting that it does have a tranquilizing effect. Inhibition of conditioned avoidance response of the rat in shuttle box and reduction of methamphetamine group toxicity with maprotiline were similar to those with amitriptyline. Maprotiline exaggerated pentetrazol convulsion, decreased muscle tone and impaired coordinated motor activity in mice to a much lesser degree than amitriptyline and imipramine. LD50 of maprotiline was approximately twice that of imipramine and three times that of amitriptyline. These results indicate that maprotiline is a new type of antidepressant, has a low toxicity and shares both potent antidepressant and some tranquilizing effect, without possessing central anticholinergic action.

UR - http://www.scopus.com/inward/record.url?scp=0016678132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016678132&partnerID=8YFLogxK

U2 - 10.1254/fpj.71.789

DO - 10.1254/fpj.71.789

M3 - Article

VL - 71

SP - 789

EP - 815

JO - Folia Pharmacologica Japonica

JF - Folia Pharmacologica Japonica

SN - 0015-5691

IS - 8

ER -